Advertisement
Research Article| Volume 7, ISSUE 3, P713-723, July 1991

Toxic Effects of Colloids in the Intensive Care unit

  • Author Footnotes
    * Associate Director, Surgical Intensive Care Unit; and Associate Professor, Departments of Anesthesiology, Surgery, and Reproductive Biology
    Howard S. Nearman
    Correspondence
    Address reprint requests to: Howard S. Nearman, MD, University Hospitals of Cleveland, Department of Anesthesiology, 2074 Abington Road, Cleveland, OH 44106
    Footnotes
    * Associate Director, Surgical Intensive Care Unit; and Associate Professor, Departments of Anesthesiology, Surgery, and Reproductive Biology
    Affiliations
    From the University Hospitals of Cleveland; and Case Western Reserve University, School of Medicine, Cleveland, Ohio
    Search for articles by this author
  • Author Footnotes
    † Associate Director, Surgical Intensive Care Unit; and Assistant Professor, Departments of Anesthesiology, Surgery, and Eeproductive Biology
    Michael L. Herman
    Footnotes
    † Associate Director, Surgical Intensive Care Unit; and Assistant Professor, Departments of Anesthesiology, Surgery, and Eeproductive Biology
    Affiliations
    From the University Hospitals of Cleveland; and Case Western Reserve University, School of Medicine, Cleveland, Ohio
    Search for articles by this author
  • Author Footnotes
    * Associate Director, Surgical Intensive Care Unit; and Associate Professor, Departments of Anesthesiology, Surgery, and Reproductive Biology
    † Associate Director, Surgical Intensive Care Unit; and Assistant Professor, Departments of Anesthesiology, Surgery, and Eeproductive Biology
DOI:https://doi.org/10.1016/S0749-0704(18)30302-6
Toxic Effects of Colloids in the Intensive Care unit
Previous ArticleSteroids and Biologic Agents in the Intensive Care Unit
Next ArticleToxicities of Parenteral Nutrition in the Critically Ill patient
      This paper is only available as a PDF. To read, Please Download here.
      Colloids are used for plasma volume expansion in the majority of critically ill patients. All colloidal solutions have the potential of causing marked fluid overload and congestive heart failure. Individual agent-specific side effects also exist and these risks must be remembered when initiating colloid solution therapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Alexander B.
        • Odake K.
        • Lawlor D.
        • et al.
        Coagulation, hemostasis, and plasma expanders: A quarter-century enigma.
        Fed Proc. 1975; 34: 1429
        • Bergentz S.E.
        • Falkheden T.
        • Olson S.
        Diuresis and urinary viscosity in dehydrated patients: Influence of dextran-40,000 with and without mannitol.
        Ann Surg. 1965; 161: 582
        • Bland J.H.
        • Laver M.B.
        • Lowenstein E.
        Vasodilator effect of commercial 5% plasma protein fraction solutions.
        JAMA. 1973; 224: 1721
        • Clift D.R.
        • Ledgerwood A.M.
        • Lucas C.E.
        • et al.
        The effect of albumin resuscitation for shock on the immune response to tetanus toxoid.
        J Surg Res. 1982; 32: 449
        • Emerson T.E.
        Unique features of albumin: A brief review.
        Crit Care Med. 1989; 17: 690
        • Faillace D.F.
        • Ledgerwood A.M.
        • Lucas C.E.
        • et al.
        Immunoglobulin changes after varied resuscitation regimen.
        J Trauma. 1982; 22: 1
        • Kirklin J.K.
        • Lell W.A.
        • Kouchoukos N.T.
        Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularization.
        Ann Thorac Surg. 1984; 37: 40
        • Kohler H.
        • Kirch W.
        • Horstmann H.J.
        Hydroxyethyl starch-induced macroamylasemia.
        Int J Clin Pharmacol. 1977; 15: 428
        • Kovalik S.G.
        • Ledgerwood A.M.
        • Lucas C.E.
        • et al.
        The cardiac effect of altered calcium homeostasis after albumin resuscitation.
        J Trauma. 1981; 21: 275
        • Ledgerwood A.M.
        • Lucas C.E.
        Postresuscitation hypertension, etiology, morbidity and treatment.
        Arch Surg. 1974; 108: 531
        • Lucas C.E.
        Renal considerations in the injured patient.
        Surg Clin North Am. 1982; 62: 133
        • Mitsuno T.
        • Ohyanagi H.
        • Naito R.
        Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA.
        Summary of 186 cases. Ann Surg. 1982; 195: 60
        • Perttila J.
        • Salo M.
        • Peltola O.
        Effects of different plasma substitutes on plasma fibronectin concentrations in patients undergoing abdominal surgery.
        Acta Anaesthesiol Scand. 1990; 34: 304
        • Puri V.K.
        • Howard M.
        • Paidipaty B.
        • et al.
        Do colloids cause coagulopathy in critically ill patients?.
        Crit Care Med. 1982; 10: 229
        • Rackow E.C.
        • Mecher C.
        • Astiz M.E.
        • et al.
        Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion.
        Crit Care Med. 1989; 17: 394
        • Replogle R.L.
        • Kundler H.
        • Gross R.E.
        Studies on the hemodynamic importance of blood viscosity.
        J Thorac Cardiovasc Surg. 1965; 50: 658
        • Rothschild M.A.
        • Oratz M.
        • Schreiber S.S.
        Albumin metabolism.
        Gastroenterology. 1973; 64: 324
        • Sasahara A.A.
        • Sharma G.V.RK.
        • Parisi A.F.
        New developments in the detection and prevention of venous thromboembolism.
        Am J Cardiol. 1979; 43: 1214
        • Savitsky J.P.
        • Doczi J.
        • Black J.
        • et al.
        A clinical safety trial of stroma-free hemoglobin.
        Clin Pharmacol Ther. 1978; 23: 73
        • Shatney C.H.
        • Deepika K.
        • Militello P.R.
        • et al.
        Efficacy of hetastarch in the resuscitation of patients with multisystem trauma and shock.
        Arch Surg. 1983; 118: 804
        • Skrede S.
        • Ro J.S.
        • Mjolnerod O.
        Effects of dextrans on the plasma protein changes during the postoperative period.
        Clin Chim Acta. 1973; 48: 143
        • Strauss R.G.
        • Stansfield C.
        • Henriksen R.A.
        • et al.
        Pentastarch may exert fewer effects on coagulation than hetastarch.
        Transfusion. 1988; 28: 257
        • Triedman J.K.
        • London M.J.
        • Hauck W.A.
        • et al.
        Pentastarch versus albumin for volume expansion following cardiac surgery.
        Anesthesiology. 1986; 65: A92

      1. Falk JL, Rackow EC, Weil MH: Colloid and crystalloid fluid resuscitation. Acute Care 10:59, 1983/84

        • Haupt M.T.
        The use of crystalloidal and colloidal solutions for volume replacement in hypovolemic shock.
        CRC Crit Rev Clin Lab Sci. 1989; 27: 1
        • Maier R.V.
        • Carrico C.J.
        • et al.
        Developments in the resuscitation of critically ill surgical patients.
        Adv Surg. 1986; 19: 271

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0749-0704(18)30302-6

      Copyright

      © 1991 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX